First Manhattan

First Manhattan’s CASI Pharmaceuticals CASI Stock Holding History

First Manhattan’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,000	Closed	-$61K	–	1380
2020 Q1	$61K	Hold	3,000	–	–	﹤0.01%	811
2019 Q4	$92K	Hold	3,000	–	–	﹤0.01%	804
2019 Q3	$100K	Hold	3,000	–	–	﹤0.01%	799
2019 Q2	$96K	Hold	3,000	–	–	﹤0.01%	824
2019 Q1	$86K	Hold	3,000	–	–	﹤0.01%	857
2018 Q4	$120K	Hold	3,000	–	–	﹤0.01%	767
2018 Q3	$140K	Hold	3,000	–	–	﹤0.01%	779
2018 Q2	$246K	Buy	+3,000	New	+$202K	﹤0.01%	661

Other funds holding CASI

IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return

Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return